Citi Keeps Hold Rating on DR Horton with $162 Price Target

Citi maintains a Hold rating on DR Horton with a $162 price target. Analyst Anthony Pettinari covers Consumer Cyclical stocks, with a 16.5% average return and 65.25% success rate. The analyst consensus is a Hold with a $155.09 average price target, a 4.67% upside from current levels. Recent corporate insider activity shows negative sentiment, with 59 insiders selling shares over the past quarter.

D.R. Horton (NYSE: DHI) has seen its price target raised by BofA Securities to $155.00 from $135.00, following its strong fiscal third-quarter 2025 earnings report. The homebuilder reported earnings per share (EPS) of $3.36, surpassing both BofA's forecast of $2.96 and the consensus estimate of $2.90. This earnings beat was attributed to stronger deliveries and improved margins, leading to a 17% single-day stock price increase, significantly outperforming the S&P 500 and homebuilding index [1].

However, despite the positive earnings report, D.R. Horton faces mixed analyst sentiment. Citi maintains a Hold rating with a $162 price target, while the analyst consensus is a Hold with an average price target of $155.09, a 4.67% upside from current levels. This discrepancy highlights the varying opinions among analysts regarding the homebuilder's future prospects [2].

Recent corporate insider activity also adds a layer of caution. Negative sentiment is evident with 59 insiders selling shares over the past quarter, signaling potential concerns about the company's future performance [2].

Forestar Group Inc. (FOR) reported its third-quarter 2025 earnings, revealing a shortfall in EPS and revenue compared to analyst expectations. Despite this miss, the company's stock rose by 4.69% in pre-market trading, reflecting investor optimism on strategic growth initiatives and market expansion efforts. Forestar Group's stock is currently undervalued at current levels, according to InvestingPro's Fair Value analysis [3].

In other recent news, DiamondRock Hospitality Company reported its first-quarter 2025 earnings, meeting EPS forecasts but falling short on revenue. The company successfully refinanced and upsized its senior unsecured credit facility to $1.5 billion, with Citi analysts updating their financial model to lower the price target to $8 from $9, maintaining a Neutral rating [1].

References:

[1] https://www.investing.com/news/analyst-ratings/dr-horton-stock-price-target-raised-to-155-from-135-at-bofa-securities-93CH-4148049
[2] https://www.investing.com/news/transcripts/earnings-call-transcript-forestar-q3-2025-misses-eps-stock-rises-93CH-4146563
[3] https://www.investing.com/news/transcripts/earnings-call-transcript-forestar-q3-2025-misses-eps-stock-rises-93CH-4146563